Skip to main content
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.040
+0.010 (0.97%)
Apr 28, 2026, 4:00 PM EDT - Market closed

RedHill Biopharma Revenue

In the year 2025, RedHill Biopharma had annual revenue of $286.00K, down -96.44%. RedHill Biopharma had revenue of $4.08M in the half year ending June 30, 2025, a decrease of -24.39%.

Revenue (ttm)
$286.00K
Revenue Growth
-95.13%
P/S Ratio
18.59
Revenue / Employee
$8,171
Employees
35
Market Cap
5.32M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025286.00K-7.76M-96.44%
Dec 31, 20248.04M1.51M23.17%
Dec 31, 20236.53M-55.27M-89.43%
Dec 31, 202261.80M-23.96M-27.94%
Dec 31, 202185.76M21.40M33.25%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biofrontera 41.71M
Sunshine Biopharma 36.31M
cbdMD 19.09M
Sonoma Pharmaceuticals 17.72M
InMed Pharmaceuticals 4.51M
China SXT Pharmaceuticals 1.54M
Akanda 836.66K
Gelteq 270.85K
Revenue Rankings

RDHL News

More News